key: cord-0961367-bnkvy68t authors: Mascaro, S.; Wu, Y.; Woodberry, O.; Nyberg, E. P.; Pearson, R.; Ramsay, J. A.; Mace, A.; Foley, D.; Snelling, T.; Nicholson, A. E. title: Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts date: 2022-02-17 journal: nan DOI: 10.1101/2022.02.14.22270925 sha: 1df6c7e235460d5beeed23fbd45f350dd739645e doc_id: 961367 cord_uid: bnkvy68t Background COVID-19 is a new multi-organ disease, caused by the SARS-CoV-2 virus, resulting in considerable worldwide morbidity and mortality. While many recognized pathophysiological mechanisms are involved, their exact causal relationships remain opaque. A better understanding is needed for predicting their progression, targeting therapeutic approaches, and improving patient outcomes. While many mathematical causal models describe COVID-19 epidemiology, none have been developed for its pathophysiology. The virus's rapid and extensive spread and therapeutic responses made this particularly difficult. Initially, no large patient datasets were publicly available, and their data remains limited. The medical literature was flooded with unfiltered, technical and sometimes conflicting pre-review reports. Clinicians in many countries had little time for academic consultations, and in-person meetings were unsafe. Methods and Findings In early 2020, we began a major project to develop causal models of the pathophysiological processes underlying the disease's clinical manifestations. We used Bayesian network (BN) models, because they provide both powerful tools for calculation and clear maps of probabilistic causal influence between semantically meaningful variables, as directed acyclic graphs (DAGs). Hence, they can incorporate expert opinion and numerical data, and produce explainable results. Dynamic causal BNs, which represent successive "time slices" of the system, can capture feedback loops and long-term disease progression. To obtain the likely causal structures, we used extensive elicitation of expert opinion in structured online sessions. Centered in Australia, with its exceptionally low COVID-19 burden, we managed to obtain many consultation hours. Groups of clinical and other subject matter specialists, all independent volunteers, were enlisted to filter, interpret and discuss the literature and develop a current consensus. We aimed to capture the experts' understanding, so we encouraged discussion and inclusion of theoretically salient latent (i.e., unobservable) variables, documented supporting literature while noting controversies, and allowed experts to propose mechanisms by extrapolation from other diseases. Intermediary experts with some combined expertise facilitated the exchange of knowledge to BN modelers and vice versa. Our method was iterative and incremental: we systematically refined and checked the group output with one-on-one follow-up meetings with the original and new experts to validate previous results. In total, 35 experts contributed 126 face-to-face hours, and could review our products. Conclusions Our method demonstrates and describes an improved procedure for developing BNs via expert elicitation, which can be implemented rapidly by other teams modeling emergent complex phenomena. The results presented are two key models, for the initial infection of the respiratory tract and the possible progression to complications, as causal DAGs and BNs with corresponding verbal descriptions, dictionaries and sources. These are the first published causal models of COVID-19 pathophysiology, with three anticipated applications: (i) making expert knowledge freely available in a readily understandable and updatable form; (ii) guiding design and analysis of observational and clinical studies, by identifying potential mediators, confounders, and modifiers of treatment effects; (iii) developing and validating parameterized automated tools for causal reasoning and decision support, in clinical and policy settings. We are currently developing such tools for the initial diagnosis, resource management, and prognosis of COVID-19, parameterized using the ISARIC and LEOSS databases. Background COVID-19 is a new multi-organ disease, caused by the SARS-CoV-2 virus, resulting in considerable worldwide morbidity and mortality. While many recognized pathophysiological mechanisms are involved, their exact causal relationships remain opaque. A better understanding is needed for predicting their progression, targeting therapeutic approaches, and improving patient outcomes. While many mathematical causal models describe COVID-19 epidemiology, none have been developed for its pathophysiology. The virus's rapid and extensive spread and therapeutic responses made this particularly difficult. Initially, no large patient datasets were publicly available, and their data remains limited. The medical literature was flooded with unfiltered, technical and sometimes conflicting pre-review reports. Clinicians in many countries had little time for academic consultations, and in-person meetings were unsafe. In early 2020, we began a major project to develop causal models of the pathophysiological processes underlying the disease's clinical manifestations. We used Bayesian network (BN) models, because they provide both powerful tools for calculation and clear maps of probabilistic causal influence between semantically meaningful variables, as directed acyclic graphs (DAGs). Hence, they can incorporate expert opinion and numerical data, and produce explainable results. Dynamic causal BNs, which represent successive "time slices" of the system, can capture feedback loops and long-term disease progression. To obtain the likely causal structures, we used extensive elicitation of expert opinion in structured online sessions. Centered in Australia, with its exceptionally low COVID-19 burden, we managed to obtain many consultation hours. Groups of clinical and other subject matter specialists, all independent volunteers, were enlisted to filter, interpret and discuss the literature and develop a current consensus. We aimed to capture the experts' understanding, so we encouraged discussion and inclusion of theoretically salient latent (i.e., unobservable) variables, documented supporting literature while noting controversies, and allowed experts to propose mechanisms by extrapolation from other diseases. Intermediary experts with some combined expertise facilitated the exchange of knowledge to BN modelers and vice versa. Our method was iterative and incremental: we systematically refined and checked the group output with one-on-one follow-up meetings with the original and new experts to validate previous results. In total, 35 experts contributed 126 face-to-face hours, and could review our products. Our method demonstrates and describes an improved procedure for developing BNs via expert elicitation, which can be implemented rapidly by other teams modeling emergent complex phenomena. The results presented are two key models, for the initial infection of the respiratory tract and the possible progression to complications, as causal DAGs and BNs with corresponding verbal descriptions, dictionaries and sources. These are the first published causal models of COVID-19 pathophysiology, with three anticipated applications: (i) making expert knowledge freely available in a readily understandable and updatable form; (ii) guiding design and analysis of observational and clinical studies, by identifying potential mediators, confounders, and modifiers of treatment effects; (iii) developing and validating parameterized automated tools for causal reasoning and decision support, in clinical and policy settings. We are currently developing such tools for the initial diagnosis, resource management, and prognosis of 1 Introduction COVID-19 is a new multi-organ disease, caused by the highly infectious SARS-CoV-2 virus, resulting in considerable worldwide morbidity and mortality. While many recognized pathophysiological mechanisms are involved-coagulation and inflammatory cascades, pulmonary exudation and respiratory compensation, endovascular and renal injury-the exact causal relationships between them remain opaque. A better understanding of these causal processes is urgent and important for predicting their progression, targeting therapeutic approaches and improving patient outcomes. To this end, the worldwide pandemic generated a flood of research, but much of the early output was unfiltered, sometimes conflicting, and of reduced reliability [1] . In contrast, no large patient datasets were publicly available, and even now, their data remains limited. In this project, we used online tools to enlist independent medical experts to interpret and iteratively discuss the evolving literature, providing us with consensus views. This process resulted in the elicitation of several detailed graphical causal models of the pathophysiology underlying the clinical manifestations of COVID-19 disease, using the kind of iterative, incremental method widely recommended for model building [2] , but rarely realized in expert knowledge elicitation. From these theoretical products, simplified models can be constructed for practical application that are parameterized using available data, e.g., for predicting the probability of a patient's future need for intensive care given their current signs, symptoms and laboratory results. In this paper, we make freely available our expert-elicited models. While there has been considerable prior work developing causal models of the transmission of SARS-CoV-2 within populations [3] [4] [5] [6] [7] [8] [9] [10] [11] , ours are the first causal models of the COVID-19 disease process within individuals. We anticipate that these models will serve three purposes, for our team and other researchers. First, they will aid communication and theoretical understanding, which includes being readily updated to incorporate new findings, and being internally and externally validated using local datasets. Second, they will guide the design and analysis of both observational and clinical studies into COVID-19, by identifying potential mediators, confounders, etc. Third, they will be used to develop and validate parameterized practical tools for causal reasoning and decision support, both in clinical and policy settings. Bayesian networks (BNs) were designed to model probabilistic causal systems. Formally, a BN [2, 12, 13] includes a directed, acyclic graph (DAG), (e.g., Fig. 1 ), which consists of nodes connected by arcs (pointing from 'parent' to 'child') that never point in a continuous sequence from a node back to itself. 1 In addition, in a BN each node represents a random variable with multiple possible states, and each arc represents a direct probabilistic dependency, quantified by a conditional probability table (CPT) or equation specifying the probability distribution of the child given the states of all its parents. In causal DAGs and BNs, these arcs also represent direct causal influences-hence they can also predict the effects of decisions regarding interventions. 1 In mathematical graph theory, where early work focused on polyhedra, these are traditionally called 'vertices' connected by 'directed edges'; but common and equivalent terms are 'nodes' connected by 'directed links', 'arrows' or 'arcs'. Modeling COVID-19 disease processes by eliciting causal BNs Mascaro et al. Virus enters URT (1) URT epithelial infection (2) Alveolar epithelial infection (5) Viremia (7) Systemic immune/inflam. response (8) Pul. capillary leakage (9) Infection related Infection of olfactory epithelium (3) Signs and symptoms Alveolar endothelial infection (6) Dry cough (10) Productive cough (11) Anosmia and/or ageusia (4) Pulmonary related URT = upper respiratory tract pul. = pulmonary inflam. = inflammatory Pulmonary capillary leakage, for example, has three 'parents' that jointly influence it, and two 'children' it influences. In the BN, provided in S1 Model, the variable it represents has states and a CPT that are not shown in the DAG. All the nodes are named, numbered, and color coded for ease of reference, and corresponding definitions for variables and arcs are given in the associated Dictionary, S1 Table, an excerpt from which is provided in Fig. 2 . Readily available software 2 allows users to enter exact or uncertain evidence about any variables, which is then efficiently propagated to 2 We used the GeNIe BN software tool (https://www. In a BN, all arcs and nodes-even 'latent' ones, i.e., not directly observable-may be defined in a semantically meaningful way (as in Fig. 1 and Fig. 2) , and this will always be so The sensation of loss of smell and/or taste occurs due infection of the cells supporting the olfactory neurons, the olfactory epithelial cells [2] . Viral tropism of the epithelial cells of the alveoli, inducing an immune response which leads to an altered cellular state (local inflammation). The upper airways act as portals for SARS-CoV-2 entry and infection of the alveolar epithelium [4] . Reduced level of oxygen in the blood. V/Q mismatch, shunt, Ventilatory insufficiency Oxygen levels in the blood are reduced due to inadequate gas exchange and perfusion and/or intrapulmonary shunting due to persistent pulmonary arterial blood flow to non-ventilated alveoli [28] , [29] 30 Acidosis Decrease in blood pH. Respiratory acidosis develops due to increased levels of carbon dioxide resulting in an increase in pH [34] . Hypoxia causes cells to undergo anaerobic metabolism resulting in an increased pH. Low levels of oxygen in the circulation. Hypoxemia can be demonstrated by low oxygen saturation measured by pulse oximetry [28] . BN Dictionary excerpt: In the Dictionaries, descriptions of the variables and arcs are provided, with selected supporting references. The variables are numbered, named and color coded as in the causal DAGs and BN files. The full Dictionaries are provided as S1 Table and S2 Table. It is common to use multiple opinions rather than relying on only one source, with the hope of obtaining a larger pool of information and greater reliability from aggregated opinions, and perhaps benefiting from mutual feedback via discussion. Group elicitation of BNs has been particularly popular in some domains, such as reliability assessment [23, 24] and environmental research [25] . When group knowledge is pooled effectively, whether by collation, consensus, averaging, or another form of amalgamation, then it tends to outperform individual knowledge [26] [27] [28] [29] [30] [31] . However, unstructured group interactions also bring welldocumented problems, e.g., diffusion of responsibility, anchoring, 'groupthink', deference to social status, and unproductive disputes [32] [33] [34] [35] [36] . Such problems can be reduced by using structured protocols, e.g., collecting independent opin- Another recommended strategy is to break down complex models into sub-models, and reuse common structures or elements when appropriate, dubbed "idioms" [42] , "templates" [40] and "network fragments" [39] . These incremental approaches adapt similar ideas long used in software engineering, such as "spiral prototyping" or "agile model building" [43] , and reusing common local structures is fundamental to "objectoriented" programming [44] . There are three major specialist roles people performed during the elicitation process, which we will refer to as follows: . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 17, 2022. ; Modeling COVID-19 disease processes by eliciting causal BNs How to divide the problem into manageable models and associated groups of experts was not obvious, since medical expertise is differentiated by more than one dimension. Some medi- To help orient our medical specialists, we provided a simple schematic Overview model indicating how these four submodels were related. However, in addition to developing the four submodels, we needed to actually synthesize them into a unified model with a view to developing practical tools to facilitate clinical reasoning and decision-making. This task was performed by our modelers in parallel, i.e., as the submodels were refined, so was the unified model. We were able to leverage the insights from submodel workshops to connect the submodels appropriately, and to prioritize the most important features and omit less important ones. We did not use separate elicitation sessions for February 14, 2022 9/32 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Despite the fact that we did not formally elicit parameters at this stage, after the workshops it was already possible from the discussion, the literature, and our understanding to roughly indicate the expected relationships (e.g., respiratory infection is highly likely to activate the immune system) with 'indicative' BN parameters. These were useful for follow up discussion, and ensured that we specified the states of the variables properly and consolidated our understanding. We also identified some typical clinical scenarios (e.g., common ways the disease progresses). We followed up with one-on-one sessions as needed, either with the same experts or supplementary experts with additional expertise. The goals were to clarify and refine the causal structure by discussing it directly, but also to perform a particular kind of validation exercise: checking that the proposed structure with indicative parameters accounted for the typical scenarios. We then presented the model to independent experts in one-on-one sessions. The stated goals were the same as the previous sessions, but if the new experts' answers did not substantially differ from those of the previous experts, then this also provided a more thorough form of validation. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. ; Modeling COVID-19 disease processes by eliciting causal BNs Mascaro et al. To conduct a group session, we followed a particular elicitation procedure (right column) guiding the introduction, efficient elicitation questions for causal structure, and the kinds of interjections from experts we encouraged. In contrast, for each one-on-one session, a customized agenda was followed with the issues and scenarios to address via more flexible interactions. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. ; Modeling COVID-19 disease processes by eliciting causal BNs . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Each week, we collectively decided which workshop to schedule next by reviewing our progress and identifying the most pressing need. We invited suitable experts with limited notice (2 weeks) but achieved good participation rates, which we attribute to a strong motivation to contribute to the pandemic response as well as, in some cases, existing relationships with our team. Since not everyone who was willing to contribute could be available at any given time, we invited more people than we could optimally accommodate, and anyone who could not attend was invited to validate the model in a subsequent round. We scheduled 2 h timeslots, since in our experience this is the minimum to introduce experts to the technology and to the problem and still have adequate time to elicit their opinions. This is also the maximum time that most of our experts could contribute (due to limited time or attention), and most indicated a preference for shorter sessions. We tried to run the sessions as efficiently as possible, but used the full 2 h in every case. Prior to each workshop, we gave participants background material that identified issues and summarized features of the model to be discussed and developed during the workshop. We used the literature review to prepare a starting template for the model. This gave our experts something to critique and expand upon, rather than starting from a blank slate, and hence expedited discussion and elicitation. We also presented a schematic overview of how each submodel would fit in with the others, and an explanation of the goals of our project. We began each workshop with a short presentation that in- The expert models will provide a theoretical rationale for, and increase confidence in, the validity of the application models. Our modelers decide which aspects of the expert models are most relevant and should be included in an application model, given its purpose and required outcomes. In some respects an application model may be simplified, e.g., by combining several latent variables. In other respects, it may be more sophisticated, e.g., by creating a DBN representing the whole system based on multiple expert BNs representing subsystems. The application models we have already developed are currently being independently validated by experts, both structurally and quantitatively, as well as validated by their fit to the data. Although we depict our methods as several linear sequences, our description should make clear . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. ; Modeling COVID-19 disease processes by eliciting causal BNs Mascaro et al. that in combination these formed a spiral process, as widely recommended for model building: i.e., our sequences of steps were iterated to produce successive improvement. Most obviously, the sequence depicted in Fig. 3 is designed to successively refine and validate elements of the model through repeated elicitation. In the same vein, we also used an adaptive elicitation procedure, i.e., we used the outcomes of elicitation and modeling exercises to help decide what sort of elicitation and modeling should be done next. So, to some extent, we learned and refined our methods over the course of the project. One example of adaptive elicitation was modifying our pre-workshop material for participants. For our early workshops, we prepared surveys on issues where we identified disagreement in the literature. We aimed to engage and prepare participants, and obtain a preliminary understanding of their views. However, despite the assistance of our coordinators, we found it difficult to design survey questions that our modelers felt were relevant to the modeling choices, yet were framed and expressed in a way that most medical experts felt they could respond to. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. ; Modeling COVID-19 disease processes by eliciting causal BNs . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. ; Modeling COVID-19 disease processes by eliciting causal BNs Mascaro et al. nity. We therefore discontinued modeling most of these details, and continued modeling the remainder in our Testing model. We have already published this as a causal BN [50] , and will not reproduce it here. We detail these procedural missteps and 'dead-ends' to accurately describe a method of modeling, whereas omitting or rewriting this history might give the misleading impression that the two models presented below were always exactly the intended output. Since COVID-19 pathophysiology is complex, we developed several BNs for different subsystems; here we present our two main products. Our Respiratory BN concerns the detailed pathways that link the initiating infection to respiratory pathophysiology and the beginning of complications, and hence it focuses primarily on the lungs. Our We present the models in three complementary types of file: 1. Causal DAGs and BNs, in which we specify the causal structures in supplementary static graph diagrams (S1 Fig., S2 Fig.) and in supplementary GeNIe BN files (S1 Model, , which summarize the processes these graphs represent ( § 3.4 and 3.6), and discuss a few unusual or controversial features ( § 3.5 and 3.7). give the definitions of variables and states, and also cite some of the research literature that supported specific BN features. We present illustrative examples in Fig. 2 , discuss some general features in § 3.8, and provide the complete documents as supplementary files (S1 Table, S2 Table) . will be presented in a future publication on this model and associated practical tools. 3 We implemented this procedure in the subsequent development of our parameterized Progression DBN. We conducted a survey and group elicitation session dedicated to background factors, where we asked experts which of the Progression variables (which do not include all the theoretical variables here) would be affected. Our Respiratory causal DAG (S1 Fig.) models the physiological process underlying COVID-19 in the respiratory system, outlining multiple and often concurrent pathways from the initial replication of the virus to key downstream complications such as multi-organ failure. We color-coded the nodes: pink for the Infection process, yellow for more detailed mechanisms relevant to the Pulmonary system, orange for those Complications that mainly arise directly from the respiratory system, and cyan for a selection of Signs and Symptoms included only for illustrative purposes. "Virus" refers to SARS-CoV-2. References have been omitted from the following description, but can be found in the associated variable entries in the BN dictionary. The direct consequences of impaired lung function, due to any of these pathways, include insufficient blood oxygenation (Hypoxemia) and excessive blood carbon dioxide (Hypercapnia), which can be measured using blood gas assays or by pulse oximetry for oxygen. Furthermore, February 14, 2022 19/32 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. We describe here four issues with our Respiratory poxics": We model the patient's perceived need for air separately from dyspnea (shortness of breath). An unusual feature of COVID has been patients who present as "happy hypoxics" (physiologically hypoxic but without symptoms) [51] . One causal hypothesis is that neurological viral infection inhibits the perceived need for air. However, at the time of modeling this connection was very speculative, so we decided not to include this pathway, pending further medical research. The vascular function (in this model) represents the ability of blood vessels to ensure sufficient blood circulation to meet the metabolic needs and energy requirements of the organs. Reduced vascular tone, Reduced vascular integrity and Hypercoagulable state are three major mechanisms that contribute to vascular dysfunction. The first two mechanisms can both lead to Reduced functional intravascular volume, i.e., less blood is available to supply the organs because of the loss of vascular tone or the shift of intravascular fluid to the interstitium (Fluid shift to interstitium) due to altered permeability (vascular integrity). The hypercoagulable state may increase the vascular resistance to flow of blood through affected vessels. Abnormally low vascular resistance is also problematic because it can lead to insufficient pressures needed to ensure the distribution of blood and perfusion of the organs. The cardiac and vascular systems closely interact. While vascular resistance and functional intravascular volume predominately drive the amount of blood available to supply organs, the heart creates the forward movement of blood needed to maintain supply to organs (organ perfusion). This is measured as Stroke volume (the volume of blood ejected for each stroke) and Cardiac output (the product of heart rate, not shown, and stroke volume). Acute cardiac inflammation and Ischemic cardiac injury can both cause abrupt or gradual deterioration in the cardiac output, either by inducing Abnormal contractility of the heart (the strength with which it pumps), or the synchronicity and efficiency with which it pumps; the latter can be manifest as abnormal heart rate or arrhythmia. Hypercoagulable state can lead to insufficient supply of blood more directly and acutely by blocking the pathway to certain parts of body; this can cause ischemic cardiac injury and pulmonary hypertension in the heart and lungs, respectively. The ultimate need of organs is enough oxygen and metabolites supplied through the blood circulation to maintain their vital functions, we have therefore replaced Hypoxia from the Respiratory model with separate nodes that distinguish between the supply of blood (as organ perfusion) and the supply of oxygen and metabolites. Reduced supply of blood will lead to reduced supply of oxygen and metabolites, and the latter will also be reduced if there is a lack of oxygen in blood (hypoxemia) even if the supply of blood is normal. All variables in these two BNs have both descriptions and their relationships with their parent nodes (supported by selected references) specified in their Dictionaries (S1 Table, S2 Table) ; a few illustrative examples are given in Fig. 2 . Here we discuss some general features. Chronic pulmonary disease in Fig. 2 illustrates that many of our variable descriptions are explicitly aligned February 14, 2022 23/32 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Methodologically, we have demonstrated how to implement best practice recommendations in a systematic, expanded procedure for developing BNs via expert elicitation. This can be emulated, adapted and refined in future projects. It is particularly well suited to projects modeling emergent diseases, since (i) it uses large-scale online expert elicitation to develop causal structure, rather than only using data or literature directly, and (ii) it produces a family of welldocumented theoretical models that make the expert knowledge freely available and that can be updated as the knowledge base develops, rather than only producing a few practical BN tools that can be derived from, and supported by, the hidden theoretical base. We demonstrated how to overcome the scarcity of data, and the exceptional abundance and unreliability of research literature, by using groups of volunteer, independent, specialist domain experts to filter, interpret and discuss the literature findings and develop a reasonable current consensus. We also utilized intermediary experts to facilitate the exchange of knowledge from domain specialists to BN modelers and vice versa. This approach is unusual, and the total number of expert hours required was exceptionally high. We obtained these hours by recruiting a large number of experts to contribute the time they could spare, which was facilitated by our extensive use of online meetings. In addition to being COVID-safe, they had the logistical ad- . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.14.22270925 doi: medRxiv preprint Modeling COVID-19 disease processes by eliciting causal BNs Mascaro et al. We followed an unusual two-phase process of BN development and publication. We aimed to first elicit relatively detailed causal models that captured the experts' understanding of the relevant processes, including theoretically salient latent variables that might not be useful in the specific, practical BN tools we aimed to subsequently develop. Furthermore, we are publishing here the full details of, and documentation for, these causal models. The goal is to make the elicited expert knowledge freely available to others in a form that can be readily updated as medical science progresses, and used for a variety of purposes. Since both the method and domain were large, complex and novel, it was necessary to subdivide, adapt and evolve both the elicitation procedure and the models. We developed a systematic approach of refining and checking the group output with one-on-one follow-up meetings as necessary, with both group members and new, independent recruits. By enlisting new domain experts, we progressively validated and refined our models in the iterative, incremental style that is broadly recommended for BN building, but is more logistically challenging and has rarely been achieved when using expert elicitation. Although we have specified our method in clear logical sequences, we stress that in model building, teams need to be flexible and in some respects progress is unpredictable. Pre-workshop questionnaires, which we abandoned, may prove more suited to other topics, especially where variables are known or easily identified beforehand; an elicitation workshop may reveal that substantial supplementary expertise or literature is required; it may become clear that models should be split or merged; and even after experts have signed off on a model it may need to be abandoned if subsequent testing with numerical datasets doesn't support it. There is also scope to refine our methods further and test some variations in future applications. For example, group workshops followed by one-on-one follow ups worked well, bringing key information and model structures together quickly (via the workshops) and then allowing more cautious validation and refinement of those structures in detail (via the follow ups). However, we now believe that conducting some oneon-one interviews may be useful earlier in the elicitation process. They may be useful prior to questionnaires to increase the chance that questions handle problematic concepts well, or prior to group workshops to provide better structure for those sessions. Medical science is constantly progressing, so our models must be refined accordingly-possibly using the method we have provided here, whether employed by us or by others. can be used to identify factors that might modify the effect of treatments, which should therefore be used to pre-specify patient subgroups. By quantifying the pathways in our models that connect proximal outcomes such as hypoxia or biomarkers to key outcomes of interest such as the need for mechanical ventilation or death, it may be possible to design more statistically efficient trials that use the former as plausible surrogate endpoints for the latter. For example, we may use the degree to which a treatment reduces hypoxia and specific biomarkers in a larger group of patients as a more statistically powerful way of quantifying the expected reduction in the need for mechanical ventilation, which eventually occurs in a smaller subset of patients. Our models will be useful in the development and/or validation of fully parameterized practical tools for causal reasoning and decision support. In addition to using them for individual decision-making in a clinical setting, such tools can also be used as an aid to policy decisionmaking at a broader level, for example, by considering risks that apply to whole populations, or the effect of non-targeted interventions applied to readily identifiable patient subgroups. All the following supplementary files will remain available on our OSF project page (https:// osf.io/bynr6/) in the versions referred to here, accompanied by any subsequent versions of them that we develop. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table. We also thank Dr Sally Shrapnel for helpful feedback on the draft of this article. Modeling COVID-19 disease processes by eliciting causal BNs Mascaro et al. 18 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 17, 2022. ; 1/5 S1 The sensation of loss of smell and/or taste occurs due infection of the cells supporting the olfactory neurons, the olfactory epithelial cells [2] . Viral tropism of the epithelial cells of the alveoli, inducing an immune response which leads to an altered cellular state (local inflammation). The upper airways act as portals for SARS-CoV-2 entry and infection of the alveolar epithelium [4] . Viral tropism of the endothelial cells of the alveoli, inducing an immune response which causes to an altered cellular state (local inflammation). SARS-CoV-2 transverse the alveolar epithelium to infect the alveolar endothelium [5] . Presence of SARS-CoV-2 in plasma allowing for systemic distribution of the virus. In COVID-19, the barrier between the upper respiratory tract (upper respiratory tract epithelium, alveolar epithelium) and circulatory system (alveolar endothelium) may be compromised causing leakage of the virus into the blood [6] . Activation of the innate and adaptive immune system due to detection of viral particles at one or more body site/s. This often results in the release of pro-and/or anti-inflammatory markers in blood by immune-related cells. Infection of the alveolar epithelial cells [7] , alveolar endothelial cells [8] , [9] , the presence of viral material in the blood [ Infection of the alveolar units including the endothelial cells [5] and associated immune response [11] , [12] damage cells resulting in increased vascular permeability and leakage of plasma into the tissues. A reflex action intended to clear the airways due to irritation without the production of mucus or phlegm. The upper respiratory tract irritation can cause dry cough. Inflammation and irritation of the lower respiratory tract can also trigger cough. [13] 11 Productive cough A reflex action intended to clear the airways due to irritation secondary to the production of mucus or phlegm. Productive cough is usually caused by the presence of secretion in the lower respiratory tract. [13] , [14] 12 Alveolar airspaces become filled with liquid, cells, tissues and other materials. Plasma leaks from the capillaries and cells migrate to the alveolar airspaces in response to infection of the epithelial cells and increased permeability of the capillaries. Cell death further simulate the infiltration of inflammatory cells and a protein-rich exudate within the alveolar space [15] , [16] . Reduced expansion (change in volume) of the lungs per unit increase in the transpulmonary pressure (at equilibrium). Infection of type II pneumocytes of the alveolar epithelium reduces surfactant secretion causing atelectasis of the lungs which, along with alveolar consolidation, reduces lung compliance [15] 14 Muscle wasting Loss of respiratory skeletal muscle over time resulting in a functional respiratory impairment. Systemic inflammation and hypoxia (feedback loop not shown) drives muscle catabolism and decreases muscle protein synthesis that then causes muscle wasting and reduced mechanical capacity of the lungs [17] . The loss of skeletal muscle mass can also be caused by immobility, aging, malnutrition, medications (not shown in this model). Note that this a slower process that occur over weeks rather than days (compared with some other events described in the model). The collective chemical and mechanical factors preventing the adequate receipt of oxygen and elimination of carbon dioxide. When alveolar consolidation reaches a certain magnitude, there is a decrease gas volume in the lungs (reduced compliance), and tidal volumes produced for a given inspiratory pressure preventing the exchange of oxygen and carbon dioxide [18] . Constriction of the vascular smooth muscles in response to low levels of alveolar oxygen or molecular promotors resulting in increased vascular resistance. Presence of viral material in the blood [10] , infection of endothelial cells [20] and the systemic immune/inflammatory response [21] activate the coagulation cascade (thrombin/ coagulation proteases, fibrinogen and platelets) inducing a hypercoagulable state as a physiological effort to repair damaged blood vessels and limit viral replication [22] . Small fragments of coagulated blood in the pulmonary circulation. Coagulation is initiated as a result of the hypercoagulable state and pulmonary endothelial injury resulting in disruption of the endothelial cell membrane manifesting a pulmonary microthrombi [23] . Blockage of pulmonary circulation. The formation of multiple microthrombi and/or larger thrombi cause emboli in the pulmonary arteries [24] . Alveolar inflammation and blood clots can lead to blockage of pulmonary circulation. High blood pressure in the pulmonary arteries. Vascular manifestations such as pulmonary and other thrombosis and sustained pulmonary vasoconstriction (which can be caused by hypoxemia) result in pulmonary hypertension due to persistently high blood pressure [21] , [25] . A state of ventilation and perfusion whereby the gas exchange is inadequate to meet the needs to oxygen delivery and carbon dioxide removal. Pulmonary circulatory blockage, Pulmonary vasoconstriction, Pulmonary capillary leakage, Alveolar consolidation V/Q mismatch can be a result of obstruction of circulation in the pulmonary arteries due to pulmonary embolism impedes blood flow and gas exchange [26] , [27] . Consolidation of the alveolar sacs due to inflammation and alveolar capillary leak reducing surface area for gas exchange [28] . Vasoconstriction helps to match regional perfusion to ventilation in the lungs. The failure of the hypoxic pulmonary vasoconstriction mechanism leads to persistent high pulmonary blood flow of poorly ventilated alveoli [29] which allows for carbon dioxide to be removed at a greater rate than the receipt of oxygen. An extreme state of V/Q mismatch where blood is shunted away from the functioning lung tissues. Pulmonary capillary leakage, Alveolar consolidation, V/Q mismatch Failure of pulmonary vasoconstriction allows for perfusion of blood to areas with inadequate ventilation due to a pulmonary capillary leakage and consolidation, worsening V/Q mismatch [30] 23 Hypoxemia Reduced level of oxygen in the blood. Oxygen levels in the blood are reduced due to inadequate gas exchange and perfusion and/or intrapulmonary shunting due to persistent pulmonary arterial blood flow to non-ventilated alveoli [28] , [29] 24 Hypercapnia Increased level of carbon dioxide in the blood. Carbon dioxide abnormally accumulates in the blood due to insufficient ventilation and inadequate gas exchange [28] , [29] Sensation of need and potential need of more oxygen. Reduced lung compliance, Hypoxemia, Hypercapnia, Acidosis Sensation of insufficient respiration (oxygen) is detected due to low oxygen levels, high carbon dioxide levels and a low pH by peripheral and central chemoreceptors. Mechanostretch receptors in the muscles and lungs also provide sensory feedback as a result of reduced compliance and respiratory muscle weakness due to altered lung mechanics [29] . Large thromboses including pulmonary arterial thrombosis and venous thrombosis. Large clots are thrombotic complications resulting from a hypercoagulable state [31] . Abnormal contractility In this model, refers to abnormal cardiac electrophysiology, resulting in an alteration in the rate and/or coordination of contractility. Systemic immune/inflam. response, Hypoxemia An hypoxic state and the immune and inflammatory response such as cytokine storm due to infection with COVID-19 can result in reduced function of the myocardial cells [21] , [32] . A reduction in the amount of blood the heart pumps per unit time. Cardiac output is a function of heart rate and stroke volume. Thrombosis can lead to reducing stroke volume by blocking blood flow, it may also trigger acute cardiac injury thus reduce contractility. Diminished myocardial contractility reduces the heart rate [21] , [28] Pulmonary hypertension can impair cardiac output by making it hard for the heart to pump out blood due to increased vascular resistance and pulmonary pressures [33] . Reduced level of tissue oxygenation. Low levels of oxygen in the blood and reduced blood flow prevents adequate oxygen delivery to the tissues [28] 30 Acidosis Decrease in blood pH. Respiratory acidosis develops due to increased levels of carbon dioxide resulting in an increase in pH [34] . Hypoxia causes cells to undergo anaerobic metabolism resulting in an increased pH. Altered function of two or more organ systems and failure to maintain homeostasis. Hypoxia, Acidosis, Other thrombosis, Viremia, Systemic immune/inflam. response, Reduced cardiac output Systemic inflammatory response and viremia can impair organ function via cell damage. Hypoxia results in cell death and subsequent organ failure [35] . Acidosis causes significant disruption in homeostasis [28] . Both hypoxia and acidosis can be caused by reduced blood flow to organs due to impaired cardiac output and thrombosis. Low levels of oxygen in the circulation. Hypoxemia can be demonstrated by low oxygen saturation measured by pulse oximetry [28] . A subjective experience of breathing discomfort (shortness of breath). Dyspnea occurs when an individual responds to the sensation of need for oxygen (e.g., hypoxemia) [29] . Multi-organ failure Multi-organ failure directly causes of death due to COVID-19 [36] . The impaired ability of the brainstem to perform baseline function including mediating sensory and motor pathways between the spinal cord and the brain, controlling brainstem reflexes, the sleepwake cycle and autonomic control of the cardiocirculatory, respiratory, digestive and immune systems. The brainstem is prone to vascular and inflammatory insults including compromised brainstem perfusion from impaired autoregulation of cerebral blood flow from sepsis; neuroinflammatory processes from excessive systemic inflammatory response; and metabolic disturbance including electrolyte disturbance and renal or liver failure [42] . The complete loss of brainstem function. Complete cessation of brainstem reflexes and functions with irreversible loss of consciousness and the capacity to breath, leading to cardiocirculatory and respiratory failure and death [42] . The impaired ability of the central nervous system to perform baseline function including normal level of consciousness and cognitive processes. Diffuse cerebral dysfunction due to the systemic inflammatory response to infection without direct central nervous system infection, mediated via excessive microglial activation, impaired cerebral perfusion, blood-brain-barrier dysfunction and altered neurotransmission. Severe hypoxemia and glucose dysregulation can potentiate dysfunction. [43] 51 Coma A state of prolonged unresponsiveness with inability to respond appropriately to stimuli. Liver dysfunction, Electrolytes and metabolites imbalance, Acidosis, Cortical brain dysfunction Significant cortical brain dysfunction from sepsis, metabolic and electrolyte disturbance may result in coma [43] . Severe liver dysfunction may result in hyperammonemia with neuronal dysfunction and cerebral edema, with progression to coma [44] . SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures Silent' Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19 The pathophysiology of 'happy' hypoxemia in COVID-19 The carnage of substandard research during the COVID-19 pandemic: a call for quality Bayesian Artificial Intelligence Dynamic models for Coronavirus Disease 2019 and data analysis Novel Coronavirus 2019 (Covid-19) epidemic scale estimation: topological network-based infection dynamics model. medRxiv Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. The Lancet Public Health Modelling the impact of COVID-19 on intensive care services in New South Wales Early dynamics of transmission and control of COVID-19: a mathematical modelling study Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province Dynamic causal modelling of COVID-19 Estimating required 'lockdown' cycles before immunity to SARS-CoV-2: Model-based analyses of susceptible population sizes, 'S0', in seven European countries including the UK and Ireland COVID-19 infection and death rates: the need to incorporate causal explanations for the data and avoid bias in testing Probabilistic Reasoning in Intelligent Systems: Networks of Plausible Inference Causation, Prediction, and Search The Cambridge Handbook of Artificial Intelligence Explaining Bayesian Networks in Natural Language: State of the Art and Challenges A method for explaining Bayesian networks for legal evidence with scenarios Explainable Bayesian Network Query Results via Natural Language Generation Systems Modeling COVID-19 disease processes by eliciting causal BNs Mascaro et al Delphi: a reevaluation of research and theory. Technological Forecasting and Social Change Network fragments: Representing knowledge for constructing probabilistic models Network engineering for agile belief network models Ontology and Bayesian decision networks for supporting the meteorological forecasting process The "Jury Fallacy" and the use of Bayesian Networks to present A spiral model of software development and enhancement Object-Oriented Programming An Evolutionary Approach Application of a technique for research and development program evaluation Overconfidence in interval estimates Reducing overconfidence in the interval judgments of experts A practical guide to structured expert elicitation using the IDEA protocol The bowtie method: A review Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling The pathophysiology of 'happy' hypoxemia in COVID-19 Cause and Norm Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures COVID-19: the vasculature unleashed A cross-talk between epithelium and endothelium mediates human alveolarcapillary injury during SARS-CoV-2 infection Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19 Endothelial cells and SARS-CoV-2: An intimate relationship Endothelial cell infection and endotheliitis in COVID-19 Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19 Pulmonary capillary leak syndrome following COVID-19 virus infection The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection Productive Cough in Children and Adolescents -View from Primary Health Care System Causes of chronic productive cough: An approach to management Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients Postmortem Examination of Patients With COVID-19 Skeletal Muscle Wasting and Function Impairment in Intensive Care Patients With Severe COVID-19 Vertical gradient of regional lung inflation in adult respiratory distress syndrome Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 Novel insights on the pulmonary vascular consequences of COVID-19 The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19 Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study Silent' Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19 The pathophysiology of 'happy' hypoxemia in COVID-19 Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dualenergy CT COVID-19 and Hypercoagulability: A Review COVID-19 and Multiorgan Response Pulmonary Arterial Hypertension: The Clinical Syndrome Physiologic Improvement in Respiratory Acidosis Using Extracorporeal Co2 Removal With Hemolung Respiratory Assist System in the Management of Severe Respiratory Failure From Coronavirus Disease Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets Clinical Features of Fatalities in Patients With COVID-19 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Endothelial cell infection and endotheliitis in COVID-19 Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures Novel insights on the pulmonary vascular consequences of COVID-19 Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19 Pulmonary Arterial Hypertension: The Clinical Syndrome Continuous positive airway pressure in COVID-19 patients with moderate-tosevere respiratory failure Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19 University of Texas Medical Branch at Galveston Pathology and Pathogenesis of Severe Acute Respiratory Syndrome Silent' Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19 The pathophysiology of 'happy' hypoxemia in COVID-19 Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization Glycocalyx and sepsisinduced alterations in vascular permeability Full article: A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications Peripheral Vascular Resistance -StatPearls -NCBI Bookshelf Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19) Renal function, electrolytes, and congestion monitoring in heart failure Pathophysiology and Treatment of Gastrointestinal Motility Disorders in the Acutely Ill Metabolic acidosis: pathophysiology, diagnosis and management Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside Hypertension and Electrolyte Disorders in Patients with COVID-19 Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series Thrombosis and COVID-19 pneumonia: the clot thickens! Effects of hypercapnia on peripheral vascular reactivity in elderly patients with acute exacerbation of chronic obstructive pulmonary disease Cerebral Circulation: XII. The Effect on Pial Vessels of Variations in The Oxygen and Carbon Dioxide Content of The Blood | Archives of Neurology & Psychiatry | JAMA Network Hypoxia, vascular smooth muscles and endothelium Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment Assessment and classification of patients with myocardial injury and infarction in clinical practice Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease Covid-19 and the cardiovascular system: a comprehensive review Heart failure and COVID-19 Liver diseases in COVID-19: Etiology, treatment and prognosis COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease Critically Ill COVID-19 Patients with Acute Kidney Injury Have Reduced Renal Blood Flow and Perfusion Despite Preserved Cardiac Function: A Case-Control Study Using Contrast-Enhanced Ultrasound SARS-CoV-2 renal tropism associates with acute kidney injury Bone Marrow and Peripheral Blood Findings in Patients Infected by SARS-CoV-2 | American Journal of Clinical Pathology | Oxford Academic The gut in COVID-19 ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults Brainstem dysfunction in critically ill patients Understanding brain dysfunction in sepsis Viral replication occurring at one or more sites of the body, primarily initiating in the nasopharynx. Converting Enzyme-2 (ACE-2), which is highly expressed in nasal epithelial cells [1] . Viral tropism of the cells of the alveoli, inducing an immune response which causes to an altered cellular state (local inflammation). The upper airways act as portals for SARS-CoV-2 entry and infection of the alveolar epithelium and endothelium [2] , [3] . Impairment of the pulmonary system capacity to oxygenate blood and removing carbon dioxide (gas exchange).Direct viral injury, Systemic immune/ inflam. response, Alveolar inflammation, Hypercoagulable stateGas exchange can be impaired due to injury of alveolar cells, pulmonary capillary leakage (caused by both the virus and immune activities), pulmonary circulatory blockage (due to microthromboses), and ventilatory insufficiency (due to reduced compliance and effort). (See details in the respiratory model) 7 High blood pressure in vascular tree of the lung. Elevated blood pressure in the lungs can be due to blood clots (microthromboses and pulmonary emboli), and vasoconstriction (triggered by hypoxemia) [4] - [6] . Inability of the lungs to perform gasexchange to oxygenate the blood and remove carbon dioxide.Pulmonary dysfunction, Pulmonary hypertension, brainstem dysfunction, Acidosis, ComaHypoventilation (brain and coma) reduces amount of new air entering the lungs for gas exchange. Pulmonary dysfunction and hypertension diminish the blood flow through the lungs. Acidosis increases the amount of carbon dioxide that needs to be exchanged. [7] 2/8 Expression of Angiotensin-converting enzyme 2 (ACE2)a protein attached to the cell membranes of cells located in the nasal epithelium, lungs, arteries, heart, kidney, and intestines. Activation of the innate and adaptive immune system due to detection of viral particles at one or more body site/s. This often results in the release of pro-and/or anti-inflammatory markers in blood by immune-related cells. Viral replication stimulates systemic immune and inflammatory response [2] , [3] , [8] . Injury to the cells caused by direct effects of viral infection. Larger quantities of virus cause more direct damage to cells. Upregulation of ACE2 receptors facilitates viral entry into cells, contributing to more direct viral injury [9] , [10] . Reduced levels of oxygen in blood. Insufficient gas exchange can reduce blood oxygen levels [11] , [12] . Increased carbon dioxide levels in blood. Insufficient gas exchange can lead to accumulation of carbon dioxide in blood [11] , [12] . Increased cardiac output above baseline to maintain tissue perfusion, in response to inappropriately low peripheral vascular tone. Hyperdynamic circulation can be triggered in response to inappropriately low peripheral vascular tone [13] . Fluid moves from the intravascular space (blood vessels) into the interstitial or "third" space. Loss of integrity increases the permeability of the vascular endothelial junction, allowing more fluid to shift into this space [14] . Refers to a deficiency in total body water. Fever, generated as part of the systemic response, increase water losses [15] . A reduction in the effective volume of blood circulating in the body. This variable captures states that result in decreased intravascular volume due to losses and sates that increase the size of the vascular basin, resulting in a relative decrease in the intravascular volume. Dehydration and fluid shift result in a reduction in the volume of blood. Reduced vascular tone increases the volume of the vascular basin, reducing the functional volume. [14] 3/8 Organ perfusion has multiple definitions. In this model, it refers to the blood flow level to perfuse (end) organs such as the kidneys and brain. Insufficient organ perfusion can be caused by not enough blood being pumped out by heart (reduced cardiac output), and thrombosis (hypercoagulable state) [14] . Decrease in vascular resistance causes reduced organ perfusion [16] . The reduced supply of oxygen and metabolites to meet the organ needs.Reduced organ perfusion (supply of blood), HypoxemiaDecreased perfusion reduces the amount of blood and the associated oxygen and metabolites delivered to an organ. Insufficient oxygen to meet the organ needs if there is lack of oxygen in blood (hypoxemia) regardless of blood supply. Abnormal concentrations of electrolytes (such as sodium, potassium, chloride, calcium, bicarbonate, phosphate, and magnesiumLiver dysfunction, Kidney dysfunction, Gut dysfunctionAbnormal renal function and gastrointestinal loses can adversely alter electrolyte balance through increased losses. Kidney dysfunction may impair the kidneys electrolyte balancing role. The liver recycles and excretes by-products of metabolism produced by other organs and tissues. These chemicals increase when the liver is impaired. [17] - [19] 22 Severely abnormal concentrations of electrolytes.Electrolytes and metabolites imbalance, Liver failure, Kidney failure, Gut failureThe kidney plays a central role in balancing electrolytes. Kidney failure impairs this homeostatic function. Similar to gut failure, kidney failure may also increase inappropriate losses of electrolytes.[17]- [19] 23 AcidosisIncreased acidity in the blood and other body tissues, altering blood oxygen carrying capacity and muscle function, including cardiac contractility.Hypercapnia, Reduced supply of oxygen and metabolites, Kidney dysfunction, Liver dysfunction, Gut dysfunctionThe kidneys, gut and respiratory system play critical roles in maintaining acid-base levels in the body. Dysfunction of these systems may result in increased loss of base (kidneys and gut) or impaired compensatory mechanisms. Carbon dioxide complexes with bicarbonate in blood to form acid. Low supply of oxygen and metabolites shifts metabolism to anaerobic, lactic acid production. The liver helps to clear this lactic acid. [20] 24 Severe acidosis Acidosis in the blood and other body tissues exceeding physiological compensatory mechanisms.Acidosis, Kidney failure, Gut failure, Respiratory failureThe kidneys, gut and respiratory system play critical roles in maintaining acid-base levels in the body. Dysfunction of these systems may result in increased loss of base or impaired compensatory mechanisms. [21] 25 Severely disrupted cellular function Severe electrolytes and metabolites imbalance, Severe acidosisIncreased acid alters cell metabolism and disturb the cell function and structure. Severe electrolytes and metabolites imbalance negatively impairs cell pathways and metabolism. [22] 26 Death Cessation of perfusion of organs contributing cell dysfunction and death. Alterations in endothelial cell viability, structure and function, compromising permeability. Decrease in the degree of constriction of a blood vessel. Endothelial cell death and dysfunction and chemical signals generated as part of the systemic response contribute to the dysregulation of tone [2] . Blood vessels are sensitive to changes in pCO2, the low pH values (hypercapnia) lead to relaxation of vascular smooth muscle [26] , [27] . Hypoxemia disrupts the control of vascular tone [28] . Refers to increase or decrease of the resistance of vessel wall. Tone and vascular resistance can increase in response to reduced functional volume to maintain perfusion. Thrombosis can result in increased resistance by vessels and restricting downstream flow. [14] 31 CoagulopathyDerangement of the balance of the coagulation cascade resulting in increased blood clotting, bleeding or a combination of both. The liver and bone marrow produce components used in clotting and organ dysfunction impairs their production. Uremia (kidney dysfunction) impairs platelet function and number. Dysfunctional systemic activation of the coagulation pathway can lead to fibrin clots, microvascular thrombosis and subsequent depletion of coagulation factors and platelets. [29] 32 Refers to the ability of the vascular system to ensure sufficient end-organ perfusion. This is a concept node that summarizes all possible causes of impaired vascular function (all vascular related nodes). Myocardial cell death due to insufficient oxygen to meet metabolic requirements. The increased cardiac output observed in hyperdynamic circulation increases the metabolic requirements of myocardial cells. Thrombosis prevents blood from reaching the myocardial cells. Hypoxemia reduces the available oxygen in blood to meet metabolic requirements. [11] , [30] 34 Altered status of myocardial cells stimulated by chemical factors released by injured cells or immunological activities. Direct viral injury damages myocardial cells. Cell damage and death and systemic immune response stimulate local inflammation [31] , [32] . Abnormal contractilityIn this model, refers to abnormal cardiac electrophysiology, resulting in an alteration in the rate and/or coordination of contractility. Inflammation and ischemia damage and kill cells impeding the flow of electrical signaling and the coordination of contractility [32] . ID Variable name Description Parent nodes Relationships with parent nodes 36 The volume of blood ejected from the heart with each left ventricular cardiac muscle contraction event or heart beat is reduced.Reduced functional intravascular volume, Ischemic cardiac injury, Acute cardiac inflammation, Pulmonary hypertension, Hyperdynamic circulation, Abnormal contractility, Vascular resistanceThe stroke volume is dependent on the volume of blood filling the left ventricle before contracting. Reduced functional intravascular volume and pulmonary hypertension lower this volume of blood. Hyperdynamic circulation reduces time for filling to occur. Ischemic cardiac injury, acute cardiac inflammation and abnormal contractility impair weaken and disrupt myocardial ability to eject from the left ventricle. Increased vascular resistance leads to reduced stroke volume via diminished ventricular compliance. [32] 37 A reduction in the amount of blood the heart pumps per unit time. Cardiac output is a function of heart rate and stroke volume. Reducing stroke volume decreases output. Abnormal contractility alters the heart rate [11] . Inability to adjust cardiac output to meet body's requirements. Electrolytes and metabolites imbalance and acidosis impair the heart muscles contractility, reducing cardiac output. [33] 39 Heart stops Cessation of cardiac contractility. Hypoxemia and poor perfusion cause cellular dysfunction. In the heart this leads to failure of electrical signaling and contractility. The impaired ability of liver to perform multiple functional activities such as protein synthesis, metabolism of substrates, including drugs, and excretion of waste products including bile.Reduced supply of oxygen and metabolites, Systemic immune/ inflam. response, Direct viral injury Viral damage, inflammation and poor nutrient supply damage and impair cellular function in the liver [34] , [35] . The inability of the liver to perform its normal synthetic and metabolic functions, such as protein synthesis, metabolism of substrates including drugs and bile excretion. Progression of liver dysfunction, which may both result from and contributed to acidosis, may lead to synthetic and metabolic function failure [36] . The impaired ability of kidney to control the body's fluid balance, maintain appropriate electrolyte concentration and eliminate substrates.Reduced supply of oxygen and metabolites, Systemic immune/ inflam. response, Direct viral injury Direct damage, inflammation and lack of nutrients impair cellular function in the kidney, altering water and electrolyte balance capacity [37] , [38] . Kidney fails to participate in multiple functional activities such as to control the body's fluid balance, maintain appropriate electrolyte concentration and eliminate substrates. Significant and widespread damage to the cells in the kidney resulting in loss of function. Acid-base, electrolytes and metabolites imbalance place competing strains on limited homeostasis capacity. [18] 44 The ability of bone marrow to produce blood cells. Bone marrow fails to produce blood cells. Significant and widespread damage to the cells in the bone marrow through lack of nutrients and direct damage [39] . The impaired ability of gut to participate in its usual functional activities such as the digestion, absorption of nutrients and the excretion of waste.Reduced supply of oxygen and metabolites, Systemic immune response, Direct viral injury Direct viral injury of enterocytes, systemic inflammation and hypoperfusion may impair gastrointestinal tract function [40] . Gut fails to participate in its usual functional activities such as the digestion, absorption of nutrients and the excretion of waste. Severe gastrointestinal dysfunction may result in gut failure with reduction of gut function below the minimum necessary for absorption of macronutrients, water and electrolytes. The metabolic and electrolyte disturbances associated with systemic sepsis and inflammation may contribute to gut failure [41] .